Market Movers Today: General Mills, Inc. (GIS), Prothena Corporation PLC (PRTA), Twitter Inc (TWTR), Southwest Airlines Co (LUV), and More
What happened: Shares of General Mills, Inc.
Prothena Corp Public Ltd Co (PRTA)
Market is closed
News
- First
- << Previous
- 21 - 29
Is Prothena Corporation PLC (PRTA) Going to Burn These Hedge Funds?
At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Third Point because we determined that some of the stocks that they are collectively...
AbbVie Inc (ABBV), Alkermes PLC (ALKS): Will Woodford Investment's Long Positions Rule the Market Again in Q4?
Woodford Investment Management is a London-based hedge fund founded in 2016 by Neil Woodford. At the end of the June quarter, Woodford managed a public equity portfolio valued at $2.13 billion.
Here's A Look At Prothena Corporation PLC (PRTA)'s Upcoming Milestones
Prothena Corporation PLC (NASDAQ:PRTA) just gave us an update as to the status of its pipeline, in doing so, presented us with some timeframes to work with from a development milestone perspective.
Prothena Corporation PLC (PRTA)’s Amyloidosis Pipeline In Focus
Prothena Corporation PLC (NASDAQ:PRTA) just offered up some insight into its ongoing phase I/II in its lead candidate, NEOD001.
Here is What Hedge Funds Think About Prothena Corporation PLC (PRTA)
Before putting in our own effort and resources into finding a good investment, we can quickly utilize hedge fund expertise to give us a quick glimpse of whether that stock could make for a good addition...
Woodford Investment Management Has A Lot Riding On These 5 Stocks
Woodford Investment Management recently filed its Form 13F with the U.S. Securities and Exchange Commission (SEC) for the reporting period of September 30.
3 Stocks Hedge Funds Were Snapping Up During the Crash
In a new filing with the U.S. Securities and Exchange Commission, William B.
Why Elan Corporation, plc (ADR) (ELN) Shouldn’t Take Royalty Pharma’s Sweetened Bid
Shunning a February $11 per share takeover bid from U.S. based pharmaceutical investment firm Royalty Pharma, Irish based Elan got a sweetened offer of up to $12 a share.
- First
- << Previous
- 21 - 29
Billionaire Hedge Funds
